Application of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatocellular carcinoma
DOI:10.3969/j.issn.1001-5256.2021.01.039
- VernacularTitle:联合肝脏离断和门静脉结扎的二步肝切除术在不可切除肝细胞癌中的应用
- Author:
Bohui LIN
1
;
Yimeng OU
Author Information
1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510000, China
- Publication Type:Research Article
- Keywords:
Carcinoma, Hepatocellular;
Hepatectomy;
Therapeutics
- From:
Journal of Clinical Hepatology
2021;37(1):180-183
- CountryChina
- Language:Chinese
-
Abstract:
For hepatocellular carcinoma patients with insufficient residual liver volume, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can achieve the goal of rapidly increasing residual liver volume and removing the tumor, but there are still drawbacks and uncertainties. As a new technique in the field of hepatobiliary surgery, the range of application of ALPPS has been expanded and its technique has been further improved in the past 10 years since its inception. This article summarizes the experience in implementing ALPPS in patients with hepatocellular carcinoma in China and globally, analyzes the key issues of the application of ALPPS in hepatocellular carcinoma patients, and discusses its opportunities and challenges in the era of targeted therapy and immunotherapy.
